[The effect of pyridinolcarbamate (anginin) on blood coagulation, fibrinolysis and thrombocytes].
D000368:Aged; D000792:Angiography; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000187:drug effects*; D001809:Blood Viscosity / Q000187:drug effects; D005263:Femoral Artery; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007383:Intermittent Claudication / Q000209:etiology; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011727:Pyridinolcarbamate / Q000494:pharmacology*; D013916:Thrombelastography; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy
D000960:Hypolipidemic Agents; D011727:Pyridinolcarbamate
Uber die Wirkung von Pyridinolkarbamat (Anginin) auf Blutgerinnung, Fibrinolyse und Thrombozyten